GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers track Body's response to lifesaving fat disorder drug
Disease control CompletedThis study monitored 11 patients with generalized lipodystrophy, a rare disorder causing severe fat loss and metabolic problems, who were starting daily metreleptin injections. The main goal was to see if their immune systems developed antibodies against the drug over three years…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE4 • Sponsor: Aegerion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for rare fat disorder: drug trial targets dangerous blood sugar and fats
Disease control CompletedThis study tested an experimental drug called REGN4461 in people with generalized lipodystrophy, a rare disorder where the body cannot store fat properly. The main goal was to see if the drug could help lower high blood sugar and high triglyceride (fat) levels in the blood. Sixte…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC